Federal Circuit Affirms Trade Commission In E. Coli Patent Row

Mealey's (August 8, 2019, 12:53 PM EDT) -- WASHINGTON, D.C. — A panel of the Federal Circuit U.S. Court of Appeals on Aug. 6 upheld a determination by the International Trade Commission (ITC) that two strains of Escherichia coli bacteria imported into the United States infringe a valid patent (Ajinomoto Co. Inc., et al..v. International Trade Commission, et al., Nos. 2018-1590, -1629, Fed. Cir., 2019 U.S. App. LEXIS 23435)....

Attached Documents

Related Sections